CIAM
MIRM icon

Caitong International Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Caitong International Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-299
Closed -$27.6K – 3282
2026
Q1 		$27.6K Buy
+299
New +$28.1K 0.01% 938
2025
Q4 		– Sell
-68
Closed -$4.99K – 2211
2025
Q3 		$4.99K Buy
68
+45
+196% +$2.86K ﹤0.01% 1226
2025
Q2 		$1.17K Sell
23
-700
-97% -$31.2K ﹤0.01% 1535
2025
Q1 		$32.6K Buy
723
+129
+22% +$6.08K 0.02% 626
2024
Q4 		$24.6K Buy
+594
New +$24.8K 0.02% 724

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's MIRM Position: Q2 2026 in Review

Caitong International Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 299 shares — an estimated $27.6K sold.

Caitong International Asset Management first reported a position in MIRM in Q4 2024 and held it in 5 quarters. The position peaked at $32.6K in Q1 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Caitong International Asset Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 299 Mirum Pharmaceuticals shares in Q2 2026, an estimated $27.6K.
  • Caitong International Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Mirum Pharmaceuticals position peaked at $32.6K in Q1 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.